Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.

Patnaik MM, Hanson CA, Sulai NH, Hodnefield JM, Knudson RA, Ketterling RP, Lasho TL, Tefferi A.

Blood. 2012 Jun 14;119(24):5674-7. doi: 10.1182/blood-2012-03-415356. Epub 2012 Apr 26.

PMID:
22538853
[PubMed - indexed for MEDLINE]
Free Article
2.

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value.

Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G, Steensma DP, Pardanani A, Hanson CA, Tefferi A.

Blood. 2012 Jan 12;119(2):569-72. doi: 10.1182/blood-2011-09-377994. Epub 2011 Nov 17.

PMID:
22096241
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.

Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.

Ann Hematol. 2006 Aug;85(8):502-13. Epub 2006 May 20.

PMID:
16715299
[PubMed - indexed for MEDLINE]
4.

Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.

Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.

Leuk Res. 2006 Aug;30(8):971-7. Epub 2006 Jan 19.

PMID:
16423393
[PubMed - indexed for MEDLINE]
5.

Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia.

Wang H, Wang XQ, Xu XP, Lin GW.

Eur J Haematol. 2009 Dec 1;83(6):550-8. doi: 10.1111/j.1600-0609.2009.01343.x. Epub 2009 Sep 8.

PMID:
19737310
[PubMed - indexed for MEDLINE]
6.

Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.

Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.

Leuk Res. 2004 Jun;28(6):587-94.

PMID:
15120935
[PubMed - indexed for MEDLINE]
7.

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ.

Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Chinese.

PMID:
19563026
[PubMed - indexed for MEDLINE]
8.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VH, Ossenkoppele GJ.

Blood. 2008 Feb 1;111(3):1067-77. Epub 2007 Oct 30.

PMID:
17971483
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts.

Seo JY, Lee KO, Kim SH, Kim K, Jung CW, Jang JH, Kim HJ.

Ann Hematol. 2014 Apr;93(4):603-8. doi: 10.1007/s00277-013-1915-x. Epub 2013 Oct 19.

PMID:
24141330
[PubMed - indexed for MEDLINE]
10.

[Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].

Wei J, Chen Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):305-11. Chinese.

PMID:
18426654
[PubMed - indexed for MEDLINE]
11.

Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.

Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.

Leuk Res. 2006 Mar;30(3):247-53. Epub 2005 Aug 15.

PMID:
16099505
[PubMed - indexed for MEDLINE]
12.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

PMID:
19135940
[PubMed - indexed for MEDLINE]
13.

Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts.

Cui R, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Zhang Y, Xiao Z.

Leuk Res. 2012 Nov;36(11):1428-33. doi: 10.1016/j.leukres.2012.08.015. Epub 2012 Aug 23.

PMID:
22921018
[PubMed - indexed for MEDLINE]
14.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
[PubMed - indexed for MEDLINE]
15.

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.

Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, Passamonti F, Invernizzi R, Castello A, Magrini U, Lazzarino M, Cazzola M.

J Clin Oncol. 2009 Feb 10;27(5):754-62. doi: 10.1200/JCO.2008.18.2246. Epub 2008 Dec 22.

PMID:
19103730
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

Bacher U, Kern W, Alpermann T, Schnittger S, Haferlach C, Haferlach T.

Leuk Res. 2012 Jul;36(7):826-31. doi: 10.1016/j.leukres.2012.04.003. Epub 2012 May 1.

PMID:
22554895
[PubMed - indexed for MEDLINE]
17.

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.

Patnaik MM, Hanson CA, Hodnefield JM, Lasho TL, Finke CM, Knudson RA, Ketterling RP, Pardanani A, Tefferi A.

Leukemia. 2012 Jan;26(1):101-5. doi: 10.1038/leu.2011.298. Epub 2011 Oct 28.

PMID:
22033490
[PubMed - indexed for MEDLINE]
18.

Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.

Wei J, Zhou XF, Zhao F, Zhou JF, Chen Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):111-6.

PMID:
19236759
[PubMed - indexed for MEDLINE]
19.

Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.

Chu SC, Wang TF, Li CC, Kao RH, Li DK, Su YC, Wells DA, Loken MR.

Leuk Res. 2011 Jul;35(7):868-73. doi: 10.1016/j.leukres.2011.02.016. Epub 2011 Mar 12.

PMID:
21397943
[PubMed - indexed for MEDLINE]
20.

Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.

Amin HM, Yang Y, Shen Y, Estey EH, Giles FJ, Pierce SA, Kantarjian HM, O'Brien SM, Jilani I, Albitar M.

Leukemia. 2005 Sep;19(9):1567-72.

PMID:
16049515
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk